Home

Fremskynde krøllet Doven non ligand estrogen pathway nf kappa fulvestrant Lover løgner Anvendelig

Cells | Free Full-Text | Estrogen-Receptor Expression and Function in  Female Reproductive Disease
Cells | Free Full-Text | Estrogen-Receptor Expression and Function in Female Reproductive Disease

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of  action | British Journal of Cancer
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer

Estrogen-induced immune changes within the normal mammary gland |  Scientific Reports
Estrogen-induced immune changes within the normal mammary gland | Scientific Reports

Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017  - Reproductive Medicine and Biology - Wiley Online Library
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)

Fulvestrant (ICI-182780) | ≥99%(HPLC) | Selleck | Estrogen/progestogen  Receptor antagonist
Fulvestrant (ICI-182780) | ≥99%(HPLC) | Selleck | Estrogen/progestogen Receptor antagonist

Endocrinotherapy resistance of prostate and breast cancer: Importance of  the NF‑κB pathway (Review)
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)

IJMS | Free Full-Text | Emerging Roles of Estrogen-Regulated Enhancer and  Long Non-Coding RNAs
IJMS | Free Full-Text | Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs

Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER

Expression of receptor activator of NFkB (RANK) drives stemness and  resistance to therapy in ER+HER2- breast cancer | Oncotarget
Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer | Oncotarget

Estrogen receptor-α signaling in post-natal mammary development and breast  cancers | SpringerLink
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink

View of Novel Breast Cancer Treatment by Targeting Estrogen Receptor-Alpha  Stability Using Proteolysis-Targeting Chimeras (PROTACs) Technology | Exon  Publications
View of Novel Breast Cancer Treatment by Targeting Estrogen Receptor-Alpha Stability Using Proteolysis-Targeting Chimeras (PROTACs) Technology | Exon Publications

Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer  Stemness: Elucidating Molecular Mechanisms and Clinical Significance
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance

Dynamic transcriptional events mediated by estrogen receptor alpha
Dynamic transcriptional events mediated by estrogen receptor alpha

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)

An overview on Estrogen receptors signaling and its ligands in breast  cancer - ScienceDirect
An overview on Estrogen receptors signaling and its ligands in breast cancer - ScienceDirect

エストロゲン/プロゲストゲン受容体阻害 | Androgen Receptor Inhibition
エストロゲン/プロゲストゲン受容体阻害 | Androgen Receptor Inhibition

Dual-mechanism estrogen receptor inhibitors | PNAS
Dual-mechanism estrogen receptor inhibitors | PNAS

Targeting Androgen/Estrogen Receptors Crosstalk in Cancer: Trends in Cancer
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer: Trends in Cancer

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of  action | British Journal of Cancer
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer

Crosstalk between Estrogen Signaling and Breast Cancer Metabolism: Trends  in Endocrinology & Metabolism
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism: Trends in Endocrinology & Metabolism

Contribution of ER and NF-κB to endocrine resistance in inflammatory breast  cancer | Breast Cancer Management
Contribution of ER and NF-κB to endocrine resistance in inflammatory breast cancer | Breast Cancer Management

IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in  Hormone-Dependent Cancers
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers

The interaction between ER and NFκB in resistance to endocrine therapy |  Breast Cancer Research | Full Text
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text

IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in  Hormone-Dependent Cancers
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers

Comparison of the roles of estrogens and androgens in breast cancer and  prostate cancer - Liu - 2020 - Journal of Cellular Biochemistry - Wiley  Online Library
Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer - Liu - 2020 - Journal of Cellular Biochemistry - Wiley Online Library

Endocrinotherapy resistance of prostate and breast cancer: Importance of  the NF‑κB pathway (Review)
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)